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Impact Factor (JCC): 6.9876 NAAS Rating: 4.14 "adequacy" or "depth" of anesthesia. Indirect assessment has been done on sedation by using subjective sedation or vital signs scales. However, under-sedation and over-sedation remains a major challenge, due to the restrictions in the subjective assessment tools. It is assumed that the consciousness is blocked by general anesthetics by suppressing the central nervous system. It is anticipated that the anesthesia's adequacy is related to some components of the electroencephalogram (EEG), since it measures the electrical motion of the brain. The hypnotic element of a continuous EEG parameter is the bi spectral index (BIS) that ranges from an awake, no drug effect value of 95 to 100 to no measurable activity of EEG with a zero value.
The BIS monitor system includes a digital signal converter, a sensor, and a monitor. The electrical signals are picked up from the cerebral cortex by the sensor and passed on to the digital signal converter. Then, the digitized signals move to the pre-processor of the device, which screens the "artifacts" (stray high-frequency signals), which are formed as a result of electro cautery equipment or patient movement. To determine the bi spectral index, the filtered EEG data is then subjected to a sophisticated algorithm, which is in the numerical level between 0-100. The BIS readings are as follows: 90-100 = fully awake; 80-90 = light sedation; 60-80 = moderate sedation; 40-60 = deep sedation; 0 = no EEG activity;
It has been recommended that the BIS can be used for titrating volatile anesthetics accurately according to specific requirements. This helps to ensure that the exposure to unwanted increased concentrations of anesthetics while decreasing the chances of mindfulness during anesthesia. 
LIDOCALNE

Pharmaeokineties
As a local anesthetic, the efficiency of lidocaine is categorized by a speedy action in-between the period of efficacy. Thus, lidocaine is appropriate for block, infiltration, and surface anesthesia. Numerous available formulations can be utilized before intubations, endoscopies, etc. pH buffering of lidocaine results in less painful local freezing. For short ophthalmic procedures, lidocaine drops are used on the eyes. When inhaled, it acts peripherally and reduces the reflex of cough.
This application can be used as a security and relief for intubated patients, since it decreases the coughing frequency and any other damage to trachea, it could cause when developing from anesthesia.
Pharinacodynainics
Signal conduction in neurons is altered by anaesthesia lidocaine by hindering the speed voltage-gated Na+ channels in the cell membrane of neurons that are accountable for the propagation of signal. With adequate blockage, the postsynaptic neuron's membrane will not depolarize and therefore will fail to conduct an voltagegated Na--channels. The anesthetic effect is created by not only avoiding pain signals from spreading to the brain, but also by preventing them before they could start. A high degree of selectivity is allowed by the cautious titration in the sensory neurons' blockage, whereas advanced concentrations also affect neuron signaling's other modalities.
Antiarrhythmic
For the action of drug in the heart, the same principle is applied. The depolarization threshold is raised by blocking the sodium channels in the conduction system as well as the heart's muscle cells, which will make the heart to decrease to start or perform early action of 241 potentials that causes an arrhythmia.
Sevoflurane Pharmacology
Sevoflurane acts mainly as GABA A receptor's positive allosteric modulator. It also potentiates glycine receptor currents, acts as an antagonist for NMDA receptor, inhibits nACh and 5-HT 3 receptor. Sevoflurane is breath in as an aesthetic, which is used to make children asleep during surgery. However, while waking up from the medication, it is observed that it causes delirium and agitation. Still, it is not known whether this can be stopped.
Pharmacokinetics
Among the recently released anesthetics for clinical use, Sevoflurane is comparatively added recently to the range of inhaling aesthetics. When compared to the older inhalational agents such as halothane or isoflurane, the most significant property of sevoflurane is that it is less soluble in the blood. The effects are rapid uptake and stimulation than the other inhalational agents, faster removal and rescue, and improved depth control of an aesthesia. The faster pharmacokinetics is an outcome of the gas partition/ low blood coefficient of 0X9.
The minimum alveolar concentration (MAC) of sevoflurane is 2.05%, with an oil/gas partition coefficient of 47.2.
Liver metabolizes 2-5% of the drug utilized. The pharmacokinetics of sevoflurane do not change in obese patients, children and in patients with renal insufficiency.
Mask induction is made feasible by pharmacokinetics and pleasant odour of sevoflurane, which is a benefit in pediatrician aesthesia. The formation of inorganic fluoride is resulted from the hepatic metabolism of sevoflurane. A minor amount of sevoflurane is decreased upon contact with alkaline CO2 absorbent, and the Impact Factor (JCC): 6.9876 NAAS Rating: 4.14 formation of a metabolite (compound A) is seen, which is inhaled in minor amounts. The question whether the compound A and inorganic fluoride are nephrotoxic is currently a subject of controversy.
Pharmacodynamics
Sevoflurane is an inhalation anesthetic agent that is used for induction and for maintaining general anesthesia. The administration of Sevoflurane is connected with a smooth, fast loss of consciousness during inhalation and a rapid retrieval when anesthesia is discontinued.
For a 40-year-old adult, minimum alveolar concentration (MAC) of sevoflurane in oxygen is 2.1%.
The MAC of sevoflurane reduces with the addition of nitrous oxide and with age.
Induction is accompanied with a minimum of upper respiratory irritation signs or excitement, no central nervous system stimulus and no indication of too much secretion within the trachea bronchieal tree. Inspired concentration is rapidly followed by the changes in the depth of sevoflurane anesthesia. Induction and recovery times were decreased in child patients who received sevoflurane.
Adverse Effects
Intracranial pressure is raised by sevoflurane and it can lead to respiratory despair. Studies inspecting a current important health concern, neurotoxicity induced by anesthetia (includes sevoflurane, especially with infants and children) are troubled with confounders, and most are statistically underpowered, and so are debated to request more data either to back up or contradict the potential link.
The safety of anesthesia when used in infants and children is concerning. The preclinical evidence from appropriate animal models have shown that the commonly used clinical essential agents, including sevoflurane, could turn to be neurotoxic to the developing brains, thus, causing neurobehavioral anomalies in the elongated term.
As of 2010, two studies, PANDA and GAS (large-scale clinical studies) are going on; to supply further important data on neuro developmental effects of general anaesthesia on young children and infants, even when sevoflurane is used.
PATIENTS AND METHODS
Study Population
This study was conducted from June 2014 to December 2014 in Erbil cardiac center after getting permission from its ethical committee. For this study, 50 patients were selected as the candidates. Selection was done with exclusion criteria consisting of patients with history of seizures, patients with history of lidocaine reaction, or the ones using drugs that affect BIS. Standard monitors were used including non-invasive and invasive arterial pressure, ECG, central venous pressure and pulse oximetry. BIS was also used to evaluate anesthesia's depth. Anesthesia was induced after 8 hours of fasting using fentanyl 2 mcg/kg i.v. followed after 3 min by propofol 1.5 --2.5_1 mg kg_l iv. When BIS touched less than 50, atracurium 0.5 mg kg i.v. was given to permit tracheal incubation. With a tidal volume of 7-8 ml/kg and an oxygen fraction of 0.4 in air, the lungs were ventilated.
To maintain an end tidal CO2 between 30 and 35 mm Hg, the respiratory rate was adjusted.
Patients were randomly distributed into 2 groups. Group B patients received 1.5 mg/ kg bolus of 2% lidocaine i.v. followed by 2 mg/kg/h infusion, whereas the patients in group A received saline in equal volumes. A P value of < 0.05 was measured as statistically significant.
Demographics and Statistical Analysis
To collect the data, a data collection sheet was designed (Fig. 6 ). The collected information was managed via SPSS v.19 computer program. From each parameter, data was expressed as meant+ standard deviation.
The measure for statistical significance is independent t-test at p value < 0.05. 
RESULTS
Among the 50 patients involved in our study, 9 (18%) were female and 41 (82%) were male. Mean weight was 7+2 and the mean age was 65.26 * 34.22 years. 50 patients were separated into 2 groups: Control (A) group (n= 25) and Lidocaine (B) group (n=25).
In this study, no patients were excluded. As per the data available in table 2, the mean dose of total bolus and infusion lidocaine was 398 + 11(mg). Immediately after induction of anesthesia, the mean concentration of Sevoflurane in the control group (A) was 1.68, 1.2 at pre-cardiopulmonary bypass stages and 1.44 at sternotomy.
In the lidocaine group (B), the mean concentration of Sevofluran was 1.36 directly after anesthesia induction, 0.4 at pro-cardiopulmonary Bypass stages and 0.84 at sternotomy (see table 3 ).
A significant difference was observed between the 2 groups based on the independent t-test concerning the doses of sevoflurane immediately after induction of anesthesia, stjterniSicony and pro-cardiopulmonary Bypass stages. 
DISCUSSIONS
This research shows that when lidocaine is given at a dose of 1.5 mg/ kg bolus followed by 2 mg/ kg/ h, it reduces the requirement of sevoflurane while keeping the BIS score between 40 and 60, during anesthesia maintenance in patients going through cardiac surgeries.
In this research, a significant statistical difference between the 2 groups have been found, which approve When cardiac surgery is performed for the patients included in this research, there was a reduction in ETsesadluraneduring the operation or along the stages of operation, also due to the use of fentanyl 10 meg/kg/dose with rnidazolam 10 ingi dose at stematomy. Due to lidocaine's action at the spinal level, by reducing the motor response, the effect of lidocaine on MAC of Sevofluranc is noted.
However, it was detected that the intravenous infusion of lidocaine decreased the requirement of bispectral index-guided sevoflurane during anesthesia.
The rate of infusion of lidocaine and the bolus dose used in this research was (398 + 11 mg) that was on par with the earlier studies which showed that this dosage did not end in plasma concentration more than 4 Meg/ ml, which is less than the toxic levels.
CONCLUSIONS
During the maintenance of general anesthesia, intravenous administration of lidocaine can significantly reduce the requirements of BIS-guided sevoflurane During BIS Guided Cardiac Surgery www.tjprc.org editor@tjprc.org
